Atrys Financial Statements From 2010 to 2025
| ATRY Stock | EUR 3.45 0.05 1.43% |
Check Atrys Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atrys Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Atrys financial statements analysis is a perfect complement when working with Atrys Health Valuation or Volatility modules.
Atrys |
Atrys Health SL Company Current Valuation Analysis
Atrys Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Atrys Health Current Valuation | 647.57 M |
Most of Atrys Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atrys Health SL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Atrys Health SL has a Current Valuation of 647.57 M. This is 95.49% lower than that of the Healthcare sector and 86.06% lower than that of the Biotechnology industry. The current valuation for all Spain stocks is 96.1% higher than that of the company.
Atrys Health SL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Atrys Health's current stock value. Our valuation model uses many indicators to compare Atrys Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atrys Health competition to find correlations between indicators driving Atrys Health's intrinsic value. More Info.Atrys Health SL is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Atrys Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Atrys Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Atrys Health Financial Statements
Atrys Health stakeholders use historical fundamental indicators, such as Atrys Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Atrys Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Atrys Health's assets and liabilities are reflected in the revenues and expenses on Atrys Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Atrys Health SL. Please read more on our technical analysis and fundamental analysis pages.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 525 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Atrys Stock
Atrys Health financial ratios help investors to determine whether Atrys Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Atrys with respect to the benefits of owning Atrys Health security.